LKQ Corporation (LON:0JSJ)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,757	7,631	10,040	11,843	12,923	7,856
Market Cap Growth	-20.57%	-23.99%	-15.23%	-8.35%	64.51%	-4.91%
Enterprise Value	10,028	11,974	14,224	14,712	15,445	10,875
Last Close Price	22.43	28.82	36.00	42.14	40.61	24.24
PE Ratio	11.14	13.85	13.66	12.42	16.04	16.81
PS Ratio	0.56	0.67	0.92	1.12	1.34	0.92
PB Ratio	1.21	1.58	2.07	2.60	3.01	1.88
P/TBV Ratio	-	-	-	29.67	36.01	42.91
P/FCF Ratio	11.67	11.79	12.81	13.88	16.29	8.44
P/OCF Ratio	8.32	8.52	9.43	11.42	12.80	7.43
EV/Sales Ratio	0.95	1.04	1.31	1.39	1.60	1.28
EV/EBITDA Ratio	6.02	8.55	10.39	10.39	11.77	10.60
EV/EBIT Ratio	10.53	11.13	12.71	12.29	14.01	13.41
EV/FCF Ratio	20.32	18.51	18.15	17.24	19.47	11.68
Debt / Equity Ratio	0.91	0.93	0.91	0.72	0.73	0.76
Debt / EBITDA Ratio	2.69	2.49	2.59	1.88	1.93	2.40
Debt / FCF Ratio	8.76	6.93	5.65	3.83	3.93	3.42
Asset Turnover	0.90	0.96	1.02	1.04	1.05	0.93
Inventory Turnover	2.64	2.75	2.82	2.82	3.09	2.71
Quick Ratio	0.57	0.47	0.44	0.56	0.62	0.70
Current Ratio	1.81	1.71	1.47	1.88	1.97	2.03
Return on Equity (ROE)	11.21%	11.35%	16.18%	20.24%	18.96%	11.89%
Return on Assets (ROA)	5.03%	5.61%	6.57%	7.31%	7.47%	5.50%
Return on Capital (ROIC)	6.44%	7.18%	8.38%	9.26%	9.29%	6.74%
Return on Capital Employed (ROCE)	9.70%	11.10%	12.10%	14.80%	14.30%	10.70%
Earnings Yield	8.98%	7.22%	7.32%	8.05%	6.24%	5.95%
FCF Yield	8.57%	8.48%	7.80%	7.20%	6.14%	11.85%
Dividend Yield	3.12%	3.33%	2.45%	2.02%	0.46%	-
Payout Ratio	44.21%	46.09%	32.27%	24.72%	6.69%	-
Buyback Yield / Dilution	2.80%	1.64%	3.49%	6.62%	2.39%	1.92%
Total Shareholder Return	5.92%	4.97%	5.94%	8.64%	2.85%	1.92%

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.